Table 2.
Treatment | DH % | Protein Solubility (%) | ζ-Potential (mV) | S₀ | D3,2 (µm) | PDI (%) |
---|---|---|---|---|---|---|
HA0 | 0 | 60.95 ± 0.90 a | −30.93 ± 0.45 a | 236.78 ± 3.00 a | - | - |
HA5 | 1 | 67.78 ± 1.57 b | −34.67 ± 0.41 b | 205.91 ± 7.46 ab | - | - |
HA10 | 2 | 72.06 ± 0.90 c | −37.53 ± 0.46 c | 193.32 ± 2.83 ab | - | - |
HA15 | 9 | 77.14 ± 0.90 d | −39.67 ± 0.36 d | 167.23 ± 7.10 ab | - | - |
HA30 | 16 | 83.65 ± 0.67 e | −43.75 ± 0.47 e | 122.64 ± 3.52 b | - | - |
EC | - | - | −23.10 ± 0.96 a | 173.07 ± 1.65 b | 14.10 ± 0.46 a | 41.55 ± 3.99 a |
EA0 | - | - | −21.47 ± 1.10 a | 244.59 ± 13.80 d | 14.73 ± 0.35 a | 30.16 ± 2.17 b |
EA5 | - | - | −28.45 ± 0.39 b | 167.12 ± 5.30 b | 0.36 ± 0.06 b | 36.99 ± 2.48 a |
EA10 | - | - | −30.65 ± 0.34 c | 147.90 ± 2.26 a | 0.14 ± 0.01 b | 17.73 ± 0.78 c |
EA15 | - | - | −33.56 ± 0.40 d | 145.71 ± 1.94 a | 0.10 ± 0.01 b | 16.31 ± 0.79 c |
EA30 | - | - | −37.60 ± 0.25 e | 135.55 ± 2.69 a | 0.10 ± 0.01 b | 14.31 ± 0.53 c |
* Values (mean ± SD) illustrated in this table are in triplicates (n = 3). For each parameter, different superscript letters indicated the significant differences among FBPC protein hydrolysates viz., slurry with adjusted pH and temperature treatment without Alcalase (HA₀), 5 min hydrolysis with Alcalase (HA₅), 10 min hydrolysis with Alcalase (HA₁₀), 15 min hydrolysis with Alcalase (HA₁₅), and 30 min hydrolysis with Alcalase (HA₃₀), and native FBPC protein (EC), FBPC protein hydrolysates viz., slurry with adjusted pH and temperature treatment without Alcalase after UHT treatment (EA₀), 5 min hydrolysis with Alcalase after UHT treatment (EA₅), 10 min hydrolysis with Alcalase after UHT treatment (EA₁₀), 15 min hydrolysis with Alcalase after UHT treatment (EA₁₅), and 30 min hydrolysis with Alcalase after UHT treatment (EA₃₀) within a column at 95% confidence level (p < 0.05).